mechanistic and exploratory, not a clinical efficacy trial
Fibroblast Migration and Collagen Synthesis BPC-157 accelerates the migration and proliferation of fibroblasts to the site of injury
At 4 mg retatrutide / 0.8 mg cagrilintide per week (the upper end of community-reported maintenance for both), the smaller vial provides roughly 3 weeks at maintenance and the larger vial roughly 5 weeks
The injectable drugs have not been approved for use in Australia, but have become widely used for weight loss, muscle growth, anti-ageing and skin improvement
Konkurrierende Ursachen mssen dafr ausgeschlossen werden, es wird nach einem plausiblen Entstehungsmechanismus gesucht
The condition often develops over months or years, so expecting resolution in days would be unrealistic